These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17981666)

  • 21. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.
    Lambeir AM; Durinx C; Scharpé S; De Meester I
    Crit Rev Clin Lab Sci; 2003 Jun; 40(3):209-94. PubMed ID: 12892317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
    Ohtsuki T; Hosono O; Kobayashi H; Munakata Y; Souta A; Shioda T; Morimoto C
    FEBS Lett; 1998 Jul; 431(2):236-40. PubMed ID: 9708910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advance of research on SDF-1/CXCR4 axis and angiogenesis in leukemia--review].
    Bao CH; He QT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):447-51. PubMed ID: 18426684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of stromal cell-derived factor-1 SDF-1/CXCL12 against proteases yields improved skin wound healing.
    Pereira RVS; EzEldeen M; Ugarte-Berzal E; Vandooren J; Martens E; Gouwy M; Ganseman E; Van Damme J; Matthys P; Vranckx JJ; Proost P; Opdenakker G
    Front Immunol; 2024; 15():1359497. PubMed ID: 39156898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade.
    Stremenova J; Krepela E; Mares V; Trim J; Dbaly V; Marek J; Vanickova Z; Lisa V; Yea C; Sedo A
    Int J Oncol; 2007 Oct; 31(4):785-92. PubMed ID: 17786309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.
    Mezawa Y; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Morimoto C; Hino O; Orimo A
    Cancer Med; 2019 Jul; 8(8):3936-3948. PubMed ID: 31140748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells.
    Guo Y; Hangoc G; Bian H; Pelus LM; Broxmeyer HE
    Stem Cells; 2005 Oct; 23(9):1324-32. PubMed ID: 16210409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy.
    Hasan AA; Hocher B
    J Mol Endocrinol; 2017 Jul; 59(1):R1-R10. PubMed ID: 28420715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of intact and truncated stromal cell-derived factor-1α in circulation by immunoaffinity enrichment and tandem mass spectrometry.
    Wang W; Choi BK; Li W; Lao Z; Lee AY; Souza SC; Yates NA; Kowalski T; Pocai A; Cohen LH
    J Am Soc Mass Spectrom; 2014 Apr; 25(4):614-25. PubMed ID: 24500701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors.
    Augustyns K; Bal G; Thonus G; Belyaev A; Zhang XM; Bollaert W; Lambeir AM; Durinx C; Goossens F; Haemers A
    Curr Med Chem; 1999 Apr; 6(4):311-27. PubMed ID: 10101215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
    Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
    J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD26/dipeptidyl peptidase IV: a regulator of immune function and a potential molecular target for therapy.
    Aytac U; Dang NH
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Mar; 4(1):11-8. PubMed ID: 15032621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
    Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
    Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.
    Mentlein R
    Regul Pept; 1999 Nov; 85(1):9-24. PubMed ID: 10588446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTH/SDF-1α cotherapy induces CD90+CD34- stromal cells migration and promotes tissue regeneration in a rat periodontal defect model.
    Wang F; Du L; Ge S
    Sci Rep; 2016 Aug; 6():30403. PubMed ID: 27480134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dipeptidyl peptidase IV (CD26) activity in the hematopoietic system: differences between the membrane-anchored and the released enzyme activity.
    Pereira DA; Gomes L; El-Cheikh MC; Borojevic R
    Braz J Med Biol Res; 2003 May; 36(5):567-78. PubMed ID: 12715075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD26 inhibition enhances perfusion recovery in ApoE-/-mice.
    Haverslag RT; de Groot D; Grundmann S; Meder B; Goumans MJ; Pasterkamp G; Hoefer IE; de Kleijn DP
    Curr Vasc Pharmacol; 2013 Jan; 11(1):21-8. PubMed ID: 23391419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity.
    Guieu R; Fenouillet E; Devaux C; Fajloun Z; Carrega L; Sabatier JM; Sauze N; Marguet D
    Behav Brain Res; 2006 Jan; 166(2):230-5. PubMed ID: 16154213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells.
    Li S; Fan Y; Kumagai A; Kawakita E; Kitada M; Kanasaki K; Koya D
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.
    Korom S; De Meester I; Stadlbauer TH; Chandraker A; Schaub M; Sayegh MH; Belyaev A; Haemers A; Scharpé S; Kupiec-Weglinski JW
    Transplantation; 1997 May; 63(10):1495-500. PubMed ID: 9175816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.